Ayala Pharmaceuticals, Inc. (ADXS) Financial Statements (2024 and earlier)

Company Profile

Business Address 9 DEER PARK DRIVE
MONMOUTH JUNCTION, NJ 08852
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
10/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:25,20841,61425,17832,36344,14170,900
Cash and cash equivalents25,20841,61425,17832,36344,14123,900
Other undisclosed cash, cash equivalents, and short-term investments      47,000
Restricted cash and investments     977 
Receivables      4,453
Prepaid expense      
Deferred costs   1,8082,3532,0722,986
Other undisclosed current assets 5511,6438651,4333,2752,904
Total current assets:25,75943,25727,85136,14950,46581,243
Noncurrent Assets
Operating lease, right-of-use asset12404,839 
Property, plant and equipment381182,3934,3506,6847,111
Intangible assets, net (including goodwill)1103,3543,2614,5754,8384,857
Goodwill      
Intangible assets, net (excluding goodwill)1103,3543,2614,5754,8384,857
Other noncurrent assets 1111182183280431
Other undisclosed noncurrent assets      
Total noncurrent assets:1713,52310,6759,10811,80212,399
TOTAL ASSETS:25,93046,78038,52645,25762,26793,642
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,1722,9232,1474,45411,83113,821
Accounts payable22874109765,6465,121
Accrued liabilities2,1502,8361,7373,4786,1858,700
Other undisclosed accounts payable and accrued liabilities      
Other liabilities    484848
Deferred revenue and credits6,995
Other undisclosed current liabilities1314,9571,1441910,993 
Total current liabilities:2,3037,8803,2914,52122,87220,864
Noncurrent Liabilities
Long-term debt and lease obligation 125,055   
Long-term debt, excluding current maturities      
Liabilities, other than long-term debt   1,2051,1551,039
Other liabilities    1,2051,1551,039
Operating lease, liability 125,055 
Other undisclosed noncurrent liabilities (12)(5,055) 14,18917,479
Total noncurrent liabilities: 125,0551,20515,34418,517
Total liabilities:2,3037,8928,3465,72638,21639,382
Equity
Equity, attributable to parent23,62738,88830,18039,53124,05154,260
Common stock214678507041
Additional paid in capital466,584467,342440,840423,750391,638355,361
Accumulated deficit(442,959)(428,600)(410,738)(384,269)(367,657)(301,142)
Total equity:23,62738,88830,18039,53124,05154,260
TOTAL LIABILITIES AND EQUITY:25,93046,78038,52645,25762,26793,642

Income Statement (P&L) ($ in thousands)

12/31/2023
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
10/31/2017
Revenues2503,24025320,8846,06312,031
Revenue, net12,031
Cost of revenue
(Cost of Goods and Services Sold)
      
Gross profit: 2503,24025320,8846,06312,031
Operating expenses(19,560)(22,026)(26,702)(38,856)(76,442)(110,559)
Operating loss:(19,310)(18,786)(26,449)(17,972)(70,379)(98,528)
Nonoperating expense(9)(1)(3)(7)(63)(0)
Other nonoperating income (expense)(9)(1)(3)(7)(63)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes    1,4173,977690
Loss from continuing operations before equity method investments, income taxes:(19,319)(18,787)(26,452)(16,562)(66,465)(97,838)
Other undisclosed income from continuing operations before income taxes 5,01097533   
Loss from continuing operations before income taxes:(14,309)(17,812)(26,419)(16,562)(66,465)(97,838)
Income tax expense (benefit)(50)(50)(50)(50)(50)4,403
Loss from continuing operations:(14,359)(17,862)(26,469)(16,612)(66,515)(93,435)
Loss before gain (loss) on sale of properties:(17,862)(26,469)(16,612)(66,515)(93,435)
Net loss attributable to parent:(14,359)(17,862)(26,469)(16,612)(66,515)(93,435)
Preferred stock dividends and other adjustments (1,025)     
Net loss available to common stockholders, diluted:(15,384)(17,862)(26,469)(16,612)(66,515)(93,435)

Comprehensive Income ($ in thousands)

12/31/2023
10/31/2022
10/31/2021
10/31/2020
10/31/2019
10/31/2018
10/31/2017
Net loss:(14,359)(17,862)(26,469)(16,612)(66,515)(93,435)
Comprehensive loss, net of tax, attributable to parent:(14,359)(17,862)(26,469)(16,612)(66,515)(93,435)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: